Doctors test gentler, tailored treatments for common throat cancer
NCT ID NCT05894083
Summary
This study is testing two personalized approaches to treat early-stage throat cancer caused by HPV. The goal is to control the cancer effectively while using less intense treatments to reduce side effects. One approach starts with surgery, and the other uses tailored radiation and chemotherapy. Researchers will track if the cancer returns and monitor treatment-related side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan Rogel Cancer Center
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.